Logo image of WELL.CA

WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis

TSX:WELL - Toronto Stock Exchange - CA94947L1022 - Common Stock - Currency: CAD

4.73  +0.06 (+1.28%)

Fundamental Rating

3

Overall WELL gets a fundamental rating of 3 out of 10. We evaluated WELL against 14 industry peers in the Health Care Providers & Services industry. WELL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, WELL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year WELL has reported negative net income.
WELL had a positive operating cash flow in the past year.
In multiple years WELL reported negative net income over the last 5 years.
WELL had a positive operating cash flow in 4 of the past 5 years.
WELL.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

With a Return On Assets value of -1.60%, WELL perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
WELL has a Return On Equity of -3.48%. This is comparable to the rest of the industry: WELL outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -1.6%
ROE -3.48%
ROIC N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
WELL.CA Yearly ROA, ROE, ROICWELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

WELL has a Gross Margin of 38.51%. This is comparable to the rest of the industry: WELL outperforms 57.14% of its industry peers.
WELL's Gross Margin has improved in the last couple of years.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
WELL.CA Yearly Profit, Operating, Gross MarginsWELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

2

2. Health

2.1 Basic Checks

WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WELL has more shares outstanding
The number of shares outstanding for WELL has been increased compared to 5 years ago.
Compared to 1 year ago, WELL has an improved debt to assets ratio.
WELL.CA Yearly Shares OutstandingWELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
WELL.CA Yearly Total Debt VS Total AssetsWELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.14, we must say that WELL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.14, WELL perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
WELL has a Debt/Equity ratio of 0.59. This is a neutral value indicating WELL is somewhat dependend on debt financing.
WELL has a better Debt to Equity ratio (0.59) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC7.59%
WELL.CA Yearly LT Debt VS Equity VS FCFWELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
WELL has a Current ratio of 0.92. This is in the better half of the industry: WELL outperforms 64.29% of its industry peers.
A Quick Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.92, WELL is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
WELL.CA Yearly Current Assets VS Current LiabilitesWELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
WELL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.19%.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%

3.2 Future

Based on estimates for the next years, WELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.87% on average per year.
WELL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.85% yearly.
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.87%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y15.85%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
WELL.CA Yearly Revenue VS EstimatesWELL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL.CA Yearly EPS VS EstimatesWELL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WELL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 18.55, the valuation of WELL can be described as rather expensive.
78.57% of the companies in the same industry are more expensive than WELL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.58, WELL is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 18.55
WELL.CA Price Earnings VS Forward Price EarningsWELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

WELL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.26
WELL.CA Per share dataWELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WELL's earnings are expected to grow with 30.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.38%
EPS Next 3Y30.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WELL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WELL HEALTH TECHNOLOGIES COR

TSX:WELL (7/14/2025, 7:00:00 PM)

4.73

+0.06 (+1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap1.20B
Analysts81.05
Price Target7.78 (64.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-661.05%
Min EPS beat(2)-1116.23%
Max EPS beat(2)-205.87%
EPS beat(4)1
Avg EPS beat(4)4130.26%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)2
Avg EPS beat(8)1642.24%
EPS beat(12)3
Avg EPS beat(12)973.71%
EPS beat(16)3
Avg EPS beat(16)622.27%
Revenue beat(2)1
Avg Revenue beat(2)-5.51%
Min Revenue beat(2)-12.61%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.92%
Revenue beat(12)7
Avg Revenue beat(12)0.22%
Revenue beat(16)11
Avg Revenue beat(16)1.27%
PT rev (1m)0%
PT rev (3m)-10.21%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)128.57%
EPS NY rev (1m)0%
EPS NY rev (3m)36.27%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)24.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)21.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.55
P/S 1.22
P/FCF N/A
P/OCF 95.87
P/B 1.43
P/tB N/A
EV/EBITDA 37.26
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY5.39%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY1.04%
SpS3.88
BVpS3.3
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.6%
ROE -3.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.51%
FCFM N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 11.42
Cap/Depr 26.64%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion 28.75%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 1.14
F-Score3
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.87%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y15.85%
EBIT growth 1Y-191.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y41.9%
FCF growth 1Y-110.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.54%
OCF growth 3Y-22.85%
OCF growth 5YN/A